Anti-inflammatory Medication of Cataract Surgery in Pseudoexfoliation Syndrome – NSAID Is Needed

References

• Ursell PG, Spalton DJ, Whitcup SM, Nussenblatt RB. Cystoid macular edema after phacoemulsification: relationship to blood–aqueous barrier damage and visual acuity. J Cataract Refract Surg. 1999;25(11):1492–97. doi:10.1016/S0886-3350(99)00196-0.
   PubMed Web of Science ®Google Scholar
• Grzybowski A, Sikorski BL, Ascaso FJ, Huerva V. Pseudophakic cystoid macular edema: update 2016. Clin Interv Aging. 2016;11:1221–29. doi:10.2147/CIA.
   PubMed Web of Science ®Google Scholar
• Chu CJ, Johnston RL, Buscombe C, Sallam AB, Mohamed Q, Yang YC. Risk factors and incidence of macular edema after cataract surgery: a database study of 81984 eyes. Ophthalmology. 2016;123(2):316–23. doi:10.1016/j.ophtha.2015.10.001.
   PubMed Web of Science ®Google Scholar
• Kessel L, Tendal B, Jorgensen KJ, Erngaard D, Flesner P, Andersen JL, Hjortdal J. Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review. Ophthalmology. 2014;121(10):1915–24. doi:10.1016/j.ophtha.2014.04.035.
   PubMed Web of Science ®Google Scholar
• McCafferty S, Harris A, Kew C, Kassm T, Lane L, Levine J, Raven M. Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo. BMC Ophthalmol. 2017. doi:10.1186/s12886-017-0405-7.
   Web of Science ®Google Scholar
• Ylinen P, Holmstrom E, Laine I, Lindholm JM, Tuuminen R. Anti-inflammatory medication following cataract surgery: a randomized trial between preservative-free dexamethasone, diclofenac and their combination. Acta Ophthalmol. 2018;96(8):853–59. doi:10.1111/aos.13843.
   PubMed Web of Science ®Google Scholar
• Kuchle M, Nguyen NX, Hannappel E, Naumann GO. The blood-aqueous barrier in eyes with pseudoexfoliation syndrome. Ophthalmic Res. 1995;27(Suppl 1):136–42. doi:10.1159/000267859.
   PubMed Web of Science ®Google Scholar
• Ilveskoski L, Taipale C, Holmström EJ, Tuuminen R. Macular edema after cataract surgery in eyes with and without pseudoexfoliation syndrome. Eur J Ophthalmol. 2019;29(5):504–509. doi:10.1177/1120672118799622.
   PubMed Web of Science ®Google Scholar
• Shingleton BJ, Crandall AS, Ahmed IIK. Pseudoexfoliation and the cataract surgeon: preoperative, intraoperative, and postoperative issues related to intraocular pressure, cataract, and intraocular lenses. J Cataract Refract Surg. 2009;35(6):1101–20. doi:10.1016/j.jcrs.2009.03.011.
   PubMed Web of Science ®Google Scholar
• Schumacher S, Nguyen NX, Kuchle M, Naumann GO. Quantification of aqueous flare after phacoemulsification with intraocular lens implantation in eyes with pseudoexfoliation syndrome. Arch Ophthalmol. 1999;117(6):733–35. doi:10.1001/archopht.117.6.733.
   PubMedGoogle Scholar
• Fontana L, Coassin M, Iovieno A, Moramarco A, Cimino L. Cataract surgery in patients with pseudoexfoliation syndrome: current updates. Clinical o et al. Cataract surgery in patients with pseudoexfoliation syndrome: current updates. Clin Ophthalmol. 2017;11:1377–83. doi:10.2147/OPTH.
   PubMed Web of Science ®Google Scholar
• Miyake K, Ota I, Miyake G, Numaga J. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery. J Cataract Refract Surg. 2011;37(9):1581–88. doi:10.1016/j.jcrs.2011.03.052.
   PubMed Web of Science ®Google Scholar
• Flach AJ, Kraff MC, Sanders DR, Tanenbaum L. The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier. Arch Ophthal. 1988;106(4):480–83. doi:10.1001/archopht.1988.01060130526028.
   PubMedGoogle Scholar
• Kim SJ, Flach AJ, Jampol LM. Nonsteroidal anti-inflammatory drugs in ophthalmology. Surv Ophthalmol. 2010;55(2):108–33. doi:10.1016/j.survophthal.2009.07.005.
   PubMed Web of Science ®Google Scholar
• Coassin M, Iovieno A, Soldani A, Cavuto S, Cimino L, Sartori A, Formisano D, Fontana L. Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome. J Cataract Refract Surg. 2016;42(8):1119–25. doi:10.1016/j.jcrs.2016.04.031.
   PubMed Web of Science ®Google Scholar
• Bambo MP, Garcia-Martin E, Otin S, Sancho E, Fuertes I, Herrero R, Satue M, Pablo L. Influence of cataract surgery on repeatability and measurements of spectral domain optical coherence tomography. Br J Ophthalmol. 2014;98:52–58. doi:10.1136/bjophthalmol-2013-303752.
   PubMed Web of Science ®Google Scholar
• Garcia-Martin E, Fernandez J, Gil-Arribas L, Polo V, Larrosa JM, Otin S, Fuertes I, Pablo L. Effect of cataract surgery on optical coherence tomography measurements and repeatability in patients with non-insulin-dependent diabetes mellitus. Invest Ophthalmol Vis Sci. 2013;54(8):5303–12. doi:10.1167/iovs.13-12390.
   PubMed Web of Science ®Google Scholar
• Yuksel N, Dogu B, Karabas VL, Kaglar Y. Foveal thickness after phacoemulsification in patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, or primary open-angle glaucoma. J Cataract Refract Surg. 2008;34(11):1953–57. doi:10.1016/j.jcrs.2008.07.016.
   PubMed Web of Science ®Google Scholar
• Miyake K, Ota I, Maekubo K, Ichihashi S, Miyake S. Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. Arch Ophthal. 1999;117(1):34–40. doi:10.1001/archopht.117.1.34.
   PubMed Web of Science ®Google Scholar
• Lee KM, Lee EJ, Kim TW, Kim H. Pseudophakic macular edema in primary open-angle glaucoma: a prospective study using spectral-domain optical coherence tomography. Am J Ophthalmol. 2017;179:97–109. doi:10.1016/j.ajo.2017.05.001.
   PubMed Web of Science ®Google Scholar
• Ahad MA, McKee HD. Stopping prostaglandin analogues in uneventful cataract surgery. J Cataract Refract Surg. 2004;30(12):2644–45. doi:10.1016/j.jcrs.2004.09.038.
   PubMed Web of Science ®Google Scholar
• Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology. 2009;116(11 Suppl):S30–36. doi:10.1016/j.ophtha.2009.06.024.
   PubMed Web of Science ®Google Scholar
• Vandenbroeck S, De Geest S, Dobbels F, Fieuws S, Stalmans I, Zeyen T. Prevalence and correlates of self-reported nonadherence with eye drop treatment: the Belgian Compliance Study in Ophthalmology (BCSO). J Glaucoma. 2011;20(7):414–21. doi:10.1097/IJG.0b013e3181f7b10e.
   PubMed Web of Science ®Google Scholar
• Hagman J. Comparison of resource utilization in the treatment of open-angle glaucoma between two cities in Finland: is more better? Acta Ophthalmol. 2013;91(Thesis 3):1–47. doi:10.1111/aos.12141.
   PubMed Web of Science ®Google Scholar
• Kessel L, Flesner P, Andresen J, Erngaard D, Tendal B, Hjortdal J. Antibiotic prevention of postcataract endophthalmitis: a systematic review and meta-analysis. Acta Ophthalmol. 2015;93(4):303–17. doi:10.1111/aos.2015.93.issue-4.
   PubMed Web of Science ®Google Scholar
• Endophthalmitis Study Group. European society of cataract & refractive surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33(6):978–88. doi:10.1016/j.jcrs.2007.02.032.
   PubMed Web of Science ®Google Scholar
• Friling E, Lundström M, Stenevi U, Montan P. Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. J Cataract Refract Surg. 2013;39(1):15–21. doi:10.1016/j.jcrs.2012.10.037.
   PubMed Web of Science ®Google Scholar